In response to Covid-19, manufacturers have quickly adapted their commercial approaches. But which of those changes are permanent? What additional capabilities do organizations need to succeed in the “new normal”? What has Covid-19 shown us about weaknesses in the traditional commercial model? To understand the extent to which the pandemic…
As leadership focuses on the trauma of Covid-19 across healthcare delivery and the challenges it presents, it is easy to forget that the traditional commercial model was under serious stress before the pandemic. Consolidation across delivery, changes in product decision-making, and growing limitations on access were making that model increasingly…
Hospitals and healthcare delivery systems are facing significant pressure to improve quality, reduce costs, and increase revenues. As a result, they are putting pressure on medical device manufacturers for lower prices and better outcomes. In addition, they’re introducing other restrictions – like reducing the number of suppliers, limiting physician access,…
It’s no secret that the healthcare industry is under growing pressure to reduce the cost of care while improving quality. Linkage of payment for healthcare to the cost and quality delivered is the idea behind value-based payment frameworks, and is the driving force behind today’s rapidly changing healthcare landscape. Such…
In July 2016, CMS’ announced that it plans to initiate a mandatory bundled-payment program in cardiology that parallels its current orthopedic bundled pricing program. This is another indication of CMS’ commitment to alternative payment models that make delivery organizations financially accountable for the cost and quality of care they provide.…
